Characterization of a New Drug-resistant Human Myeloma Cell Line That Expresses P-Glycoprotein

Cancer Research

Volumn 46, Issue 10, 1986, Pages 5125-5130

  Dalton, William S ^a   Durie, Brian G M ^a   Alberts, David S ^a   Gerlach, James ^b   Cress, Anne E ^a  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITY OF ARIZONA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACRONINE; DEXAMETHASONE; DOXORUBICIN; DOXORUBICIN C 14; GLYCOPROTEIN P; IDARUBICIN; MELPHALAN; MITOXANTRONE; RADIOISOTOPE; UNCLASSIFIED DRUG; VINCRISTINE;

ARTICLE; BLOOD AND HEMOPOIETIC SYSTEM; CANCER CHEMOTHERAPY; CELL LINE; CROSS RESISTANCE; DRUG RESISTANCE; HUMAN; HUMAN CELL; MULTIPLE MYELOMA; PRIORITY JOURNAL; THERAPY; TUMOR CELL;

CARBON RADIOISOTOPES; CELL LINE; CELL SURVIVAL; DOXORUBICIN; DRUG RESISTANCE; GLYCOPROTEINS; HUMANS; MULTIPLE MYELOMA; P-GLYCOPROTEIN;

EID: 0022485356     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: None     Document Type: Article

References (41)

1. Salmon, S. E., Haut, A., Bonnet, J. D., Amare, M., Weick, J. K., Dune, B.G.M., and Dixon, D. O. Alternating combination chemotherapy and levamisole improves survival in multiple myeloma: a Southwest Oncology Group Study. J. Clin. Oncol., 1:453-461,1983.
2. Durie, B.G.M., Dixon, D. O., Carter, S., Stephens, R., Rivkin, S., Bonnet, J., Lyubica, D., Salmon, S., Files, J. C., and Costanz, J. J. Improved survival duration with combination chemotherapy induction for multiple myeloma (Abstract). Blood, 66(Suppl. 1): 214, 1985.
3. Alexanian, R., Salmon, S., Bonnet, J., Gehan, E., Haut, A., and Weick, J. Combination therapy for multiple myeloma. Cancer (Phila.), 40:2765-2771, 1977
4. Kyle, R. A. Long-term survival in multiple myeloma. N. Engl. J. Med., 308: 314-316,1983.
5. Hofmann, V., Salmon, S. E., and Durie, B. G.M. Drug resistance in multiple myeloma associated with high in vitro incorporation of3H-thymidine. Blood, 58:471-476, 1981.
6. Durie, B. G.M., Young, L. A., and Salmon, S. E. Human myeloma in vitro colony growth: interrelationships between drug sensitivity, cell kinetics, and patient survival duration. Blood, 61:929-934,1983.
7. Ling, V., and Thompson, L. H. Reduced permeability in CHO cells as a mechanism of resistance to colchicine. J. Cell. Physiol., 83:103-116, 1983.
8. Bech-Hansen, N. T., Till, J. E., and Ling, V. Pleiotropic phenotype of colchicine resistant CHO cells: cross-resistance and collateral sensitivity. J. Cell. Physiol., 88:23-32, 1976.
9. Biedler, J. L., Chang, T., Meyers, M. B., Peterson, R. H.F., and Spengler, B. A. Drug resistance in Chinese hamster lung and mouse tumor cells. Cancer Treat. Rep., 67:859-867,1983.
10. Alberts, D. S., and Salmon, S. E. Adriamycin (NSC-123127) in the treatment of alkylator-resistant multiple myeloma: A pilot study. Cancer Chemother. Rep., 59:345-350, 1975.
11. Alberts, D. S., Durie, B. G.M., and Salmon, S. E. Doxorubicin/BCNU chemotherapy for multiple myeloma in relapse. Lancet, 1:926-928,1976.
12. Barlogie, B., Smith, L., and Alexanian, R. Effective treatment of advanced multiple myeloma refractory to alkylating agents. N. Engl. J. Med., 316: 1353-1356,1984.
13. Giavazzi, R., Scholar, E., and Hart, I. R. Isolation and preliminary characterization of an adriamycin-resistant murine fibrosarcoma cell line. Cancer Res., 43: 2216-2222,1983.
14. Johnson, R. K., Chitnis, M. P., Embrey, W. M., and Gregory, E. B. In vivo characteristics of resistance and cross-resistance of an adriamycin-resistant subline of P388 leukemia. Cancer Treat. Rep., 62: 1535-1547,1978.
15. Skovsgaard, T. Mechanism of cross-resistance between vincristine and daunorubicin in Ehrlich ascites tumor cells. Cancer Res., 38:4722-4727,1978.
16. Dano, K. Development of resistance to adriamycin (NSC-123127) in Ehrlich ascites tumor in vivo. Cancer Chemother. Rep., 56:321-326,1972.
17. Kartner, N., Shales, M., Riordan, J. R., and Ling, V. Daunorubicin-resistant Chinese hamster ovary cells expressing multidrug resistance and a cell-surface P-glycoprotein. Cancer Res., 43:4413-4419,1983.
18. Carman, D. and Center, M. S. Alterations in cell surface membranes in Chinese hamster lung cells resistant to adriamycin. Biochem. Biophys. Res. Commun., 105:157-163,1982.
19. Bhalla, K., Hindenburg, A., Taub, R. N., and Grant, S. Isolation and characterization of an anthracycline-resistant human leukemic cell line. Cancer Res., 45:3657-3662,1985.
20. Matsuoka, Y., Moore, G. E., Yagi, Y., and Pressman, D. Production of free light chains of immunoglobulin by a hematopoietic cell line derived from a patient with multiple myeloma. Proc. Soc. Exp. Biol. Med., 125:1246-1250, 1967.
21. Hamburger, A. W., and Salmon, S. E. Primary bioassay of human tumor stem cells. Science (Wash. DC) 197:461-463, 1977.
22. Salmon, S. E., Hamburger, A. W., Soehnlen, B. J., Durie, B. G.M., Alberts, D. S., and Moon, T. E. Quantitation of differential sensitivity of human tumor stem cells to anticancer drugs. N. Engl. J. Med., 298: 1321-1327, 1978.
23. Durie, B. G.M., and Salmon, S. E. High speed scintillation autoradiography. Science (Wash. DC), 190:1093-1095, 1975.
24. Bataille, R., Durie, B. G.M., Sany, J., and Salmon, S. E. Myeloma bone marrow acid phosphatase staining: A correlative study of 38 patients. Blood, 55:802-805,1980.
25. Seigneurin, D., David, J., Sotto, J. J., and Hollard, D. β-Glucuronidases plasmocytaires dans les dysglobulinemies. Interest dianostique de leur mise en evidence. Pathol. Biol. (Paris), 27:467-471, 1979.
26. Trent, J. M., Durie, B. G.M., and Davis, J. R. Cytogenetic analysis of leukemic colonies from acute and chronic myelogenous leukemia. Br. J. Cancer, 47:103-109,1983.
27. Riordan, J. R., and Ling, V. Purification of P-glycoprotein from plasma membrane vesicles of Chinese hamster ovary cell mutants with reduced colchicine permeability. J. Biol. Chem., 254:12701-12705, 1979.
28. Fairbanks, G., Steck, T. L., and Wallach, D. H.F. Electrophoretic analysis of the major polypeptides of the human erythrocyte membrane. Biochemistry, 10:2606-2617, 1971.
29. Debenham, P. G., Kartner, N., Siminovitch, L., Riordan, J. R., and Ling, V. DNA-mediated transfer of multiple drug resistance and plasma membrane glycoprotein expression. Mol. Cell. Biol., 2:881-889,1982.
30. Towbin, H., Staehelin, T., and Gordon, J. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: Procedure and some applications. Proc. Natl. Acad. Sci. USA, 76:4350-4354, 1979.
31. Kartner, N., Evernden-Porelle, D., Bradley, G., and Ling, V. Detection of P-glycoprotein in multidrug-resistant cell lines by monoclonal antibodies. Nature (Lond.), 316:820-823, 1985.
32. Vistica, D. T., Toal, J. N., and Rabinowitz, M. Amino acid-conferred protection against melphalan. Characterization of melphalan transport and correlation of uptake with cytotoxicity in cultured LI210 leukemia cells. Biochem. Pharmacol., 27:2865-2870,1975.
33. Peng, Y. M., Davis, T. P., and Alberts, D. S. High performance liquid chromatography of a new anticancer drug, ADCA-physiochemical properties and pharmacokinetics. Life Sci., 29:361-369,1981.
34. Anderson, K. C., Bates, M. P., Slaughenhoupt, B., Schlossman, S. F., and Nadler, L. M. A monoclonal antibody with reactivity restricted to normal and neoplastic plasma cells. J. Immunol., 132:3172-3179,1984.
35. Riordan, J. R., and Ling, V. Genetic and biochemical characterization of multidrug resistance. Pharmac. Ther., 28:51-75, 1985.
36. Kartner, N., Riordan, J. R., and Ling, V. Cell surface P-glycoprotein associated with multidrug resistance in mammalian cell lines. Science (Wash. DC), 221:1285-1288,1983.
37. Beck, W. T., Mueller, T. J., and Tanzer, L. R. Altered surface membrane glycoproteins in Vinca-alkaloid-resistant human leukemic lymphoblasts. Cancer Res., 39:2070-2076, 1979.
38. Bell, R. D., Gerlach, J. H., Kartner, N., Buick, R. N., and Ling, V. p-Glycoprotein expression in ovarian cancer evidence for multidrug resistance. J. Clin. OncoL, 3:311-315,1985.
39. Roninson, I. B., Abelson, H. T., Housman, D. E., Howell, N., and Varshavsky, A. Amplification of specific DNA sequences correlates with multi–drug resistance in Chinese hamster cells. Nature (Lond.) 309:626-628,1984.
40. BeU, D. R., Trent, J. M., Willard, H. F., Riordan, J. R., and Ling, V. Chromosomal location of human P-glycoprotein gene sequences. Cancer Genet Cytogenet., in press.
41. Salmon, S. E., Shadduck, R. K., and Schilling, A. Intermittent high-dose prednisone (NSC-10023) therapy for multiple myeloma. Cancer Chemother. Rep., 51:179-187,1967.